OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

Rhea-AI Summary

OptimizeRx Corp. (Nasdaq: OPRX) announced a conference call on March 8, 2023, at 4:30 p.m. Eastern Time to discuss its fourth-quarter and fiscal year results for 2022. The financial results will be released prior to the call, which will include a Q&A session with management. OptimizeRx connects over 60% of U.S. healthcare providers and patients through its advanced health technology solutions, enhancing medication access and adherence. Interested parties can join the call via a toll-free number or webcast, and a replay will be available on the Investors section of the company's website for 12 months.

Positive

• Scheduled conference call to discuss financial results improves transparency.
• Strong connectivity with over 60% of U.S. healthcare providers indicates robust market presence.

Negative

• None.

ROCHESTER, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, will hold a conference call on Wednesday, March 8, 2023 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and fiscal year, ended December 31, 2022. The financial results will be issued in a press release prior to the call.

OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:

Date:	Wednesday, March 8, 2023
Time:	4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1600324&tp_key=1bf1fbca3f
Toll Free:	1-888-886-7786
International:	1-416-764-8658
Conference ID:	26399560

Please call the conference telephone number or log on to the web access link five minutes prior to the start time.

A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at www.optimizerx.com/investors.  

About OptimizeRx
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.

For more information, follow the Company on Twitter, LinkedIn, or visit www.optimizerx.com.  

Important Cautions Regarding Forward Looking Statements 
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

OptimizeRx Contact 
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com

Media Relations Contact 
Kimberley Sirk, Media Relations Manager 
ksirk@optimizerx.com

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

FAQ

When is the OptimizeRx conference call to discuss fiscal year results?

The conference call is scheduled for March 8, 2023, at 4:30 p.m. Eastern Time.

What financial information will OptimizeRx share on its conference call?

OptimizeRx will discuss its results for the fourth quarter and fiscal year ended December 31, 2022.

How can I listen to the OptimizeRx conference call?

You can listen via a toll-free number or access the webcast at the provided link.

Will a replay of the OptimizeRx conference call be available?

Yes, a replay will be available for 12 months on the Investors section of the OptimizeRx website.

What is OptimizeRx's primary business focus?

OptimizeRx focuses on providing point-of-care technology solutions to help patients start and stay on therapies.